• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国食品药品监督管理局批准上市的噩梦:是认知还是现实?

The nightmare of FDA clearance/approval to market: perception or reality?

作者信息

Tylenda C A

机构信息

Division of Dental Infection Control and General Hospital Devices, US Food and Drug Administration, Rockville, MD 20895, USA.

出版信息

Technol Health Care. 1996 Sep;4(3):259-67.

PMID:8931236
Abstract

Over the last few years the Center for Device Evaluation and Research (CDRH) at the Food and Drug Administration (FDA) has received annually over 16 thousand submissions related to medical devices. Over 10,000 of these are major submissions which include applications to conduct clinical trials and applications to market medical devices for a specified indication for use. Each application is carefully considered. FDA personnel work closely with applicants to ensure that clinical trial design minimizes risk to the patients and maximizes benefit with respect to addressing the safety and effectiveness of the device being tested. Applicants are given every opportunity to provide additional information when necessary to assure that applications to market medical devices are complete. Applicants have the opportunity to meet with FDA staff prior to submitting applications in cases where the application is other than a straight forward, uncomplicated submission. In addition, FDA assists applicants through the development of guidance documents, which discuss the type of information that would be beneficial to include in a submission. The Division of Small Manufacturers Assistance at FDA is dedicated to helping interested persons understand the clearance/approval process. This paper will discuss the role of FDA in the regulation of medical devices, with an emphasis on the pathway to obtaining permission to market medical devices in the United States.

摘要

在过去几年中,美国食品药品监督管理局(FDA)的器械评估与研究中心(CDRH)每年收到超过1.6万份与医疗器械相关的申报材料。其中超过1万份是主要申报材料,包括进行临床试验的申请以及为特定使用适应症销售医疗器械的申请。每份申请都经过仔细审议。FDA工作人员与申请人密切合作,以确保临床试验设计将对患者的风险降至最低,并在解决受试器械的安全性和有效性方面使益处最大化。必要时,会给予申请人一切机会提供额外信息,以确保医疗器械上市申请的完整性。在申请并非简单直接的情况下,申请人有机会在提交申请前与FDA工作人员会面。此外,FDA通过制定指导文件来协助申请人,这些文件讨论了在申报材料中包含哪些有益信息。FDA的小型制造商援助部门致力于帮助相关人士了解审批流程。本文将讨论FDA在医疗器械监管中的作用,重点是在美国获得医疗器械上市许可的途径。

相似文献

1
The nightmare of FDA clearance/approval to market: perception or reality?美国食品药品监督管理局批准上市的噩梦:是认知还是现实?
Technol Health Care. 1996 Sep;4(3):259-67.
2
Medical devices containing materials derived from animal sources (except for in vitro diagnostic devices), guidance for FDA reviewers and industry; availability--FDA. Notice.含动物源材料的医疗器械(体外诊断器械除外),给美国食品药品监督管理局审评人员和行业的指南;可用性——美国食品药品监督管理局。通知。
Fed Regist. 1998 Nov 6;63(215):60009-10.
3
Medical devices; retention in class III and effective date of requirement for premarket approval for three preamendments class III devices--FDA. Proposed rule; opportunity to request a change in classification.医疗器械;三类器械的保留以及三项修订前的三类器械上市前批准要求的生效日期——美国食品药品监督管理局。拟议规则;请求变更分类的机会。
Fed Regist. 1998 Jul 30;63(146):40673-7.
4
FDA medical device approval: things you didn't learn in medical school or residency.美国食品药品监督管理局医疗器械审批:你在医学院或住院医师培训期间没学到的东西。
Am J Orthop (Belle Mead NJ). 2007 Aug;36(8):407-12.
5
New FDA draft guidance on premarket submissions.美国食品药品监督管理局关于上市前申报的新草案指南。
Med Device Technol. 1999 Oct;10(8):12-4.
6
Technology assessment of medical devices at the Center for Devices and Radiological Health.设备与放射健康中心对医疗设备的技术评估。
Am J Manag Care. 1998 Sep 25;4 Spec No:SP129-35.
7
Medical devices; implementation of third party review under the Food and Drug Administration Modernization Act of 1997; emergency processing request under OMB review--FDA. Notice.医疗器械;根据1997年《食品药品管理局现代化法案》实施第三方审查;行政管理和预算局审查下的紧急处理请求——美国食品药品管理局。通知。
Fed Regist. 1998 May 22;63(99):28388-91.
8
FDA modernization act of 1997: guidance on medical device tracking; availability--FDA. Notice.1997年《食品药品监督管理局现代化法案》:医疗器械追踪指南;可用性——食品药品监督管理局。通知。
Fed Regist. 1998 Mar 4;63(42):10640-1.
9
Safe Medical Devices Act: management guidance for hospital compliance with the new FDA requirements.《安全医疗器械法案》:医院遵守美国食品药品监督管理局新要求的管理指南
Hosp Technol Ser. 1993 Oct;12(11):1-27.
10
Medical devices; exemptions from premarket notification and reserved devices; class I--FDA. Notice.医疗器械;免于上市前通知和保留器械;I类——美国食品药品监督管理局。通知。
Fed Regist. 1998 Feb 2;63(21):5387-93.